Latest Period
Q1 2026
Security Snapshot
Bluejay Diagnostics, Inc. - Common Stock, par value $0.0001 per share (BJDX) Institutional Ownership
CUSIP: 095633608
13F Institutional Holders and Ownership History from Q4 2025 to Q1 2026
Institutions Reporting
6
Shares (Excl. Options)
58,829
Price
$1.84
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- BJDX on Nasdaq
- Shares outstanding
- 972,603
- Reported price per share
- $1.92
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 58,829
- Total reported value
- $108,244
- Portfolio coverage rank
- 0%
- Share change
- +58,828
- Value change
- +$108,243
- Number of holders
- 6
Security identity
Issuer context
Latest holder snapshot
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- BJDX - Bluejay Diagnostics, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 095633608.
- 6 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 6 between Q4 2025 and Q1 2026.
- Reported value moved from $1 to $108,244.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 6 institutions filings for Q1 2026.
Security key
095633608
Latest holder period
Q1 2026
13F holders
6
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
BJDX full holder history
Bluejay Diagnostics, Inc. SEC filings
Bluejay Diagnostics, Inc. company facts
Bluejay Diagnostics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 095633608:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
BJDX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Braeden Lichti | 3.6% | -27% | $115,375 | 35,500 | 0% | Braeden Lichti | 11 Mar 2026 | |
| NORTHSTRIVE FUND II LP | 3.6% | -27% | $115,375 | 35,500 | 0% | Braeden Lichti | 11 Mar 2026 |
As of 31 Mar 2026, 6 institutional investors reported holding 58,829 shares of Bluejay Diagnostics, Inc. - Common Stock, par value $0.0001 per share (BJDX). This represents 6% of the company’s total 972,603 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
2
Latest
Q1 2026
Rows shown
1-2 of 2